{"url_path":"/sec/imrx/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1790340/0001790340-26-000057-index.html","accession_number":"0001790340-26-000057","cik":"0001790340","ticker":"IMRX","issuer_name":"Immuneering Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1790340/0001790340-26-000057-index.html","primary_entity_key":"0001790340","primary_entity_name":"Immuneering Corp"},"word_count":287,"has_tables":true,"body_markdown":"Item 6. Exhibits\n\nEXHIBIT INDEX\n\nIncorporated by ReferenceFiled/\nFurnished\nHerewith\n\nExhibit NumberExhibit DescriptionFormFile No.ExhibitFiling\nDate\n\n3.1\n[Amended and Restated Certificate of Incorporation of Immuneering Corporation](https://www.sec.gov/Archives/edgar/data/1790340/000155837021012336/imrx-20210630xex3d1.htm)\n10-Q001-406753.19/9/2021\n\n3.2\n[Amended and Restated Bylaws of Immuneering Corporation](https://www.sec.gov/Archives/edgar/data/1790340/000110465924010041/tm245037d1_ex3-1.htm)\n\n8-K\n001-406753.12/2/2024\n\n4.1\n[Form of Pre-Funded Warrant](https://www.sec.gov/Archives/edgar/data/1790340/000110465925081995/tm2524079d1_ex4-1.htm)\n8-K001-406754.18/25/2025\n\n4.2\n[Form of Purchase Warrant](https://www.sec.gov/Archives/edgar/data/1790340/000110465925081995/tm2524079d1_ex4-2.htm)\n8-K001-406754.28/25/2025\n\n10.1#\n[Immuneering Corporation Non-Employee Director Compensation Program, as amended, effective January 1, 2026](https://www.sec.gov/Archives/edgar/data/1790340/000179034026000042/imrx-20251231x10kxexx1015.htm)\n10-K001-4067510.153/6/2026\n\n100\n\n[Table of Contents](#i4eee5ae3edd24e9494ec3773a97df51f_7)\n\nIncorporated by ReferenceFiled/\nFurnished\nHerewith\n\nExhibit NumberExhibit DescriptionFormFile No.ExhibitFiling\nDate\n\n31.1\n[Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a).](imrx-20260331xex311.htm)\n*\n\n31.2\n[Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a).](imrx-20260331xex312.htm)\n*\n\n32.1\n[Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350.](imrx-20260331xex321.htm)\n**\n\n32.2\n[Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350.](imrx-20260331xex322.htm)\n**\n\n101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.*\n\n101.SCHInline XBRL Taxonomy Extension Schema Document.*\n\n101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.*\n\n101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.*\n\n101.LABInline XBRL Taxonomy Extension Label Linkbase Document.*\n\n101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.*\n\n104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*\n\n*    Filed herewith.\n\n**    Furnished herewith.\n\n# Indicates management contract or compensatory plan.\n\n101\n\n[Table of Contents](#i4eee5ae3edd24e9494ec3773a97df51f_7)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized.\n\nIMMUNEERING CORPORATION\n\nDate: May 15, 2026\nBy:/s/ Benjamin J. Zeskind\n\nName:Benjamin J. Zeskind, Ph.D.\n\nTitle:Co-Founder, President, Chief Executive Officer and Director (Principal Executive Officer)\n\nDate: May 15, 2026\nBy:/s/ Mallory Morales\n\nName:Mallory Morales\n\nTitle:SVP Finance, Chief Accounting Officer and Treasurer\n(Principal Financial Officer and Principal Accounting Officer)\n\n102"}